Molecular and Cellular Basis of Alzheimer's Disease

Dear Colleagues,

Alzheimer’s disease (AD) is the main contributor to dementia worldwide, a cognitive syndrome that progressively and fatally impairs the ability of the affected individuals to perform essential everyday tasks. Dementia is also the major cause of disability among elderly people worldwide, and its derived social and economic costs are massive. Although the molecular and cellular basis of AD remains a matter of intense scientific investigation and has been partially uncovered, several crucial aspects related to the neuropathology of AD still require our attention and interest. These aspects, although not exhaustive, may involve the following actions: uncovering currently unknown idiopathic triggering factors, shedding light on the molecular mechanisms of neuropathology onset, understanding common neuropathological mechanisms that defy brain cell heterogeneity, identifying potential early-onset biological diagnostic and prognostic markers (neuropathology onset proposed as early as 20 years before clinical diagnosis). Thus, this Special Issue focuses on generating genuine and valuable scientific knowledge on the molecular and cellular basis of AD, with foresight on the apparition of novel diagnosis and therapeutic strategies for this fatal neurological disorder.

You may choose our Joint Special Issue in NeuroSci, or Joint Special Issue in Cells.

Dr. Xavier Gallart-Palau
Dr. Aida Serra
Prof. Dr. Giulio Pasinetti
Dr. Joyce Harary
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.